Human Metabolome Technologies (TSE:6090) Other Operating Expense: 円670 Mil (TTM As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Human Metabolome Technologies Inc TSE:6090

52 GF Score

Price 円600.00

GF Value 円799.59

Valuation Modestly Undervalued

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Human Metabolome Technologies Other Operating Expense?

Human Metabolome Technologies TSE:6090 -0.66% 52 Other Operating Expense is 円670 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 52/100 and a GF Value™ of 円799.59 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Human Metabolome Technologies's Other Operating Expense for the three months ended in Dec. 2025 was 円167 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was 円670 Mil.

Human Metabolome Technologies's quarterly Other Operating Expense declined from Jun. 2025 (円179 Mil) to Sep. 2025 (円167 Mil) and declined from Sep. 2025 (円167 Mil) to Dec. 2025 (円167 Mil).

Human Metabolome Technologies's annual Other Operating Expense declined from Jun. 2022 (円649 Mil) to Jun. 2023 (円649 Mil) but then increased from Jun. 2023 (円649 Mil) to Jun. 2024 (円649 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Human Metabolome Technologies Other Operating Expense Related Terms

Human Metabolome Technologies Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Other Operating Expense Chart

Human Metabolome Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Operating Expense

Get a 7-Day Free Trial

873.76

766.65

648.85

648.77

649.16

Human Metabolome Technologies Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Other Operating Expense	Get a 7-Day Free Trial															159.15	179.11	167.45	167.23	156.38

52GF Score

Human Metabolome Technologies Inc TSE:6090

Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Human Metabolome Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円670 Mil.

Frequently Asked Questions Learn more about Other Operating Expense →

What does a Other Operating Expense of 円670 Mil mean?

Human Metabolome Technologies (TSE:6090) has a Other Operating Expense of 円670 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Human Metabolome Technologies and its competitors.

Is Human Metabolome Technologies' Other Operating Expense too high?

Human Metabolome Technologies' current Other Operating Expense is 円670 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Human Metabolome Technologies' Other Operating Expense compare to TMO and DHR?

Human Metabolome Technologies' Other Operating Expense of 円670 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Other Operating Expense for a Medical Diagnostics & Research company?

A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Other Operating Expense mean?

A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Other Operating Expense is 円670 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Human Metabolome Technologies stock overvalued right now?

Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円799.59, compared to a current price of 円600.00 — trading 25% below its estimated fair value. The current Other Operating Expense is 円670 Mil. Human Metabolome Technologies' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Other Operating Expense calculated?

Other Operating Expense is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Other Operating Expense is 円670 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円600.00 is trading 25% below its estimated GF Value™ of 円799.59. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

Other Operating Expense: 円670 Mil
GF Value™: 円799.59 vs. price of 円600.00 (25% below fair value)
GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →